These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The place of a peripheral vasodilator agent in the treatment of shock states]. Lareng L; Jorda MF; Cathala B; Mathelin D Anesth Analg (Paris); 1974; 31(1):41-51. PubMed ID: 4210208 [No Abstract] [Full Text] [Related]
4. [Pathophysiology of heart failure: peripheral vascular and muscular mechanisms]. Kiowski W Ther Umsch; 1993 Jun; 50(6):394-400. PubMed ID: 8351668 [TBL] [Abstract][Full Text] [Related]
5. [Pathomechanisms of heart failure]. Urbaszek W Z Arztl Fortbild (Jena); 1993; 87(8 Suppl 4):1-4. PubMed ID: 8105608 [No Abstract] [Full Text] [Related]
6. Compensatory mechanisms in congestive heart failure--the role of the peripheral resistance vessels. Zelis R; Mason DT N Engl J Med; 1970 Apr; 282(17):962-4. PubMed ID: 4908071 [No Abstract] [Full Text] [Related]
7. [Neurohumoral regulation in heart failure]. Riegger GA; Muders F; Luchner A Z Kardiol; 1996; 85 Suppl 6():205-10. PubMed ID: 9064967 [TBL] [Abstract][Full Text] [Related]
8. Vascular adjustments during the development of shock. Nickerson M Can Med Assoc J; 1970 Oct; 103(8):853-9. PubMed ID: 5476315 [No Abstract] [Full Text] [Related]
9. Vasodilator treatment of heart failure. Taylor SH Practitioner; 1981 Oct; 225(1360):1419-29. PubMed ID: 7329932 [No Abstract] [Full Text] [Related]
10. [Use of vasodilator agents in the treatment of cardiac insufficiency]. Ruano Calvo FJ; Larman Tellechea M; Pajarón López A Med Clin (Barc); 1984 Oct; 83(11):460-8. PubMed ID: 6150138 [No Abstract] [Full Text] [Related]
11. [Functional significance of the sympathetic vasodilator effect in skeletal muscle]. Berdina NA; Kolenko OA; Kots IaM; Rodionov IM Dokl Akad Nauk SSSR; 1971; 197(5):1218-21. PubMed ID: 5090842 [No Abstract] [Full Text] [Related]
14. Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications. Dávila DF; Núñez TJ; Odreman R; de Dávila CA Int J Cardiol; 2005 Jun; 101(3):343-6. PubMed ID: 15907399 [TBL] [Abstract][Full Text] [Related]
15. [Hypertension and the sympathetic nervous system: research to pursue. Interview by Robert Henry]. de Champlain J Union Med Can; 1990; 119(5):294-5, 298-300. PubMed ID: 2238281 [No Abstract] [Full Text] [Related]
16. [Activity of preganglionic sympathetic single fibers during experimental coronary occlusion]. Malliani A; Pagani M; Recordati G; Schwartz PJ; Zanchetti A; Bartorelli C Atti Soc Ital Cardiol; 1968; 2():189-90. PubMed ID: 5717504 [No Abstract] [Full Text] [Related]
17. Failure of many new heart-failure drugs: the need for vasoconstrictor rather than vasodilator agents? Cleland JG Br J Hosp Med; 1994 Sep 7-20; 52(5):193, 195-6. PubMed ID: 7820314 [No Abstract] [Full Text] [Related]
18. [On the role of the sympathetic nervous system in the pathogenesis of the Raynaud phenomenon secondary to the use of vibrating instruments. 3. Effect of noradrenaline]. Casula D; Nissardi GP; Gessa GL; Spinazzola A; Sanna-Randaccio F Boll Soc Ital Biol Sper; 1968 Feb; 44(3):144-7. PubMed ID: 5687947 [No Abstract] [Full Text] [Related]
19. Physiology and pathophysiology of baroreceptor function and neuro-hormonal abnormalities in heart failure. Kirchheim HR; Just A; Ehmke H Basic Res Cardiol; 1998; 93 Suppl 1():1-22. PubMed ID: 9833126 [No Abstract] [Full Text] [Related]
20. [The role of sympathetic nervous system in heart failure]. Abramovitch N; Hoffman A; Winaver J Harefuah; 1992 Apr; 122(8):513-8. PubMed ID: 1398322 [No Abstract] [Full Text] [Related] [Next] [New Search]